Aldactone belongs to the potassium-sparing class, meaning it does not promote potassium loss like loop or thiazide diuretics. This makes it useful when clinicians want to avoid hypokalaemia while still achieving mild diuresis.
Yes, spironolactone is approved as monotherapy for hypertension, especially in patients who have resistant hypertension or a tendency toward low potassium levels.
Blood-pressure reduction may be observed within a few weeks, but full effect can take up to 2-3 months as the drug alters fluid balance and vascular tone.
Spironolactone is metabolised in the liver, so mild hepatic impairment is usually tolerated. Severe liver dysfunction, however, increases the risk of fluid accumulation and hyperkalaemia, and dosing should be adjusted.
Gynecomastia is a recognised side effect; patients should discuss the symptom with their prescriber, who may lower the dose, switch to an alternative potassium-sparing agent, or consider surgical referral if the condition persists.
Potassium supplements can raise serum potassium to unsafe levels when combined with spironolactone. It is advisable to avoid them unless a healthcare professional explicitly recommends supplementation.
Spironolactone may increase serum potassium and bicarbonate levels, potentially influencing the interpretation of electrolyte panels. Communicating medication use to the laboratory is recommended.
Spironolactone is not a prohibited substance by the World Anti-Doping Agency, but athletes should disclose its use to their sport’s medical team to avoid any regulatory misunderstandings.
Unused tablets should be returned to a pharmacy medication-return scheme or disposed of in a sealed container placed in household waste, following the UK NHS guidelines for safe drug disposal.
The active ingredient, spironolactone, is the same worldwide, but tablet imprint codes, excipients, and packaging may vary by manufacturer and region. Always verify the imprint and dosage strength before use.
Aldactone is the brand name for the generic drug spironolactone, an active ingredient classified as a potassium-sparing diuretic within the heart and blood-pressure therapeutic category. It is supplied as oral pills in strengths of 25 mg and 100 mg. In the United Kingdom, spironolactone is a prescription-only medicine (POM) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Spironolactone blocks the actions of aldosterone, a hormone that signals the kidneys to retain sodium and water while excreting potassium. By antagonising the mineralocorticoid receptor, Aldactone reduces sodium reabsorption, promoting mild diuresis and preventing potassium loss. The onset of diuretic effect typically occurs within a few hours, with peak activity reached after 6-12 hours and a duration of action lasting up to 24 hours. Because the drug is well absorbed from the gastrointestinal tract, oral bioavailability is high, and it undergoes hepatic metabolism to several active metabolites, the most important being canrenone.
Aldactone is approved in the UK for the following indications:
These approvals are based on clinical evidence that spironolactone effectively lowers blood pressure, reduces fluid overload, and corrects electrolyte disturbances caused by aldosterone excess.
Spironolactone has been studied for several off-label uses that are supported by peer-reviewed research:
Off-label use requires medical supervision and individualized risk assessment.
Ideal candidates are adults with hypertension, heart-failure-related fluid retention, or confirmed hyperaldosteronism who require a potassium-sparing diuretic.
These effects are usually transient and resolve with continued therapy or dose adjustment.
This article provides educational information about Aldactone and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
